MRAM
Everspin Technologies, Inc.
MRAM has slightly lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over MRAM overall, supported by stronger fundamentals and stronger modeled upside.
MRAM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
MRAM's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
MRAM PE Valuation
MRAM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 105x next year's earnings.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
MRAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect MRAM to return to profit, with revenue growing. However, they disagree widely on these estimates.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
MRAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.12 | — |
| Q3 2026 | -$0.40 | -$0.39 |
MRAM lost $0.40 per share over the past year, a bigger loss than the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over MRAM in the latest year-over-year earnings comparison.
MRAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.6M | +47% |
| Q2 2026 | $18.7M | +42% |
| Q1 2026 | $14.9M | +13% |
| Q4 2025 | $14.8M | +12% |
MRAM's revenue has grown year over year every quarter since late 2025: $21M last quarter, up 47% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -23% | -8.5 points |
| Q1 2026 | -18% | -3.6 points |
| Q4 2025 | -7.2% | +4.5 points |
| Q3 2025 | -11% | N/A |
| Q2 2025 | -15% | N/A |
| Q1 2025 | -15% | N/A |
| Q4 2024 | -12% | N/A |
MRAM's operating margin was −23% last quarter, down 8.5 points from the same quarter a year ago, near the bottom of its range since 2024.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over MRAM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over MRAM on profitability, with a higher operating margin.
MRAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.2M | -138% |
| Q1 2026 | -$3.8M | -818% |
| Q4 2025 | -$975K | -147% |
SNDK has the edge over MRAM in the latest year-over-year cash flow comparison.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over MRAM in the latest year-over-year cash flow comparison.
MRAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +745K shares |
| 1 year | +6.1% | +1.4M shares |
MRAM has 24M diluted shares, up 6.1% from a year ago.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over MRAM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MRAM Net Leverage
MRAM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
MRAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 19.9 | Oversold |
MRAM's weekly RSI is 44 (neutral) and its Stochastic is 20 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
MRAM PE vs Technology Sector
| Metric | MRAM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MRAM has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
MRAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.7 | 12% below |
| 20 week MA | $15.8 | 18% below |
| 50 week MA | $15.7 | 17% below |
| 100 week MA | $11.2 | 16% above |
| 200 week MA | $9.38 | 38% above |
MRAM has stronger trend alignment. MRAM is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
MRAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.38 | $4.64 | -14% |
| 2021 | $4.64 | $11.1 | +139% |
| 2022 | $11.1 | $5.27 | -53% |
| 2023 | $5.27 | $9.04 | +72% |
| 2024 | $9.04 | $6.57 | -27% |
| 2025 | $6.57 | $9.38 | +43% |
| 2026 YTD | $9.38 | $12.9 | +38% |
MRAM's yearly returns have swung widely, from +139% in 2021 to −53% in 2022. It's up 38% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over MRAM on returns for 2026, with the stronger performance.